drugset / Trial / NCT00556387

Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection

NCT00556387 ↗

Phase 2 Withdrawn University of Arkansas
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the possible effects of an anesthetic agent called Ketamine on the injured brain in children. The researchers think that it will effect the outcomes of children with these injuries.

Timeline

Start
2008-12
Primary completion
2012-12
Completion
2012-12

Outcome

Outcome not reported

Stopped: “This study has been withdraw from the IRB. The PI has transferred to another university. The IND was transferred.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous